DE3887635D1 - Verfahren zur Herstellung von Produkten von Fremdgenen. - Google Patents

Verfahren zur Herstellung von Produkten von Fremdgenen.

Info

Publication number
DE3887635D1
DE3887635D1 DE88118584T DE3887635T DE3887635D1 DE 3887635 D1 DE3887635 D1 DE 3887635D1 DE 88118584 T DE88118584 T DE 88118584T DE 3887635 T DE3887635 T DE 3887635T DE 3887635 D1 DE3887635 D1 DE 3887635D1
Authority
DE
Germany
Prior art keywords
ltr
downstream
foreign gene
products
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE88118584T
Other languages
English (en)
Other versions
DE3887635T2 (de
Inventor
Toshiya Takano
Minoru S H Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3887635D1 publication Critical patent/DE3887635D1/de
Publication of DE3887635T2 publication Critical patent/DE3887635T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE3887635T 1987-11-09 1988-11-08 Verfahren zur Herstellung von Produkten von Fremdgenen. Expired - Lifetime DE3887635T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28289387 1987-11-09

Publications (2)

Publication Number Publication Date
DE3887635D1 true DE3887635D1 (de) 1994-03-17
DE3887635T2 DE3887635T2 (de) 1994-06-01

Family

ID=17658465

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3887635T Expired - Lifetime DE3887635T2 (de) 1987-11-09 1988-11-08 Verfahren zur Herstellung von Produkten von Fremdgenen.

Country Status (6)

Country Link
US (2) US5646013A (de)
EP (1) EP0316717B1 (de)
AT (1) ATE101198T1 (de)
CA (1) CA1309044C (de)
DE (1) DE3887635T2 (de)
ES (1) ES2061604T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318500A4 (de) * 1986-08-01 1989-12-22 Genetics Inst Induzierbare expression hohen spiegels für heterologe gene.
CA2059317A1 (en) * 1991-01-15 1992-07-16 Yi Zeng Immuno-enzymatic test for detection of hiv-1 antibody
US5665873A (en) * 1995-02-09 1997-09-09 Dana Farber Cancer Institute Glucocorticoid response elements
FR2782732A1 (fr) * 1998-08-28 2000-03-03 Transgene Sa Systeme d'expression inductible
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
CA2524619A1 (en) * 2005-11-22 2007-05-22 Ottawa Health Research Institute Novel stem cells, nucleotide sequences and proteins therefrom

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
US4374927A (en) * 1981-02-24 1983-02-22 The Board Of Trustees Of The Leland Stanford Jr. University Extrachromosomal regulation of expression
EP0105141A3 (de) * 1982-09-09 1985-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Rekombinante DNS Moleküle, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Hepatitis B Oberflächen-Antigen (HBsAg) und pharmazeutische Zusammensetzungen die das HBsAg enthalten
JPH0630590B2 (ja) * 1985-08-30 1994-04-27 株式会社ヤクルト本社 複合プラスミドベクタ−
EP0213628A3 (de) * 1985-09-03 1988-09-21 Yeda Research And Development Company, Ltd. Expression von Superoxiddismutase in eukaryotischen Zellen
EP0318500A4 (de) * 1986-08-01 1989-12-22 Genetics Inst Induzierbare expression hohen spiegels für heterologe gene.
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays

Also Published As

Publication number Publication date
DE3887635T2 (de) 1994-06-01
US5646013A (en) 1997-07-08
ATE101198T1 (de) 1994-02-15
EP0316717A1 (de) 1989-05-24
US5534419A (en) 1996-07-09
CA1309044C (en) 1992-10-20
ES2061604T3 (es) 1994-12-16
EP0316717B1 (de) 1994-02-02

Similar Documents

Publication Publication Date Title
ATE323169T1 (de) Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren
FI880899A0 (fi) Oleellisesti puhdas DNA ja RNA ja menetelmä erytropoietiinin ekspressoimiseksi
DE3886221D1 (de) VERFAHREN ZUR HERSTELLUNG VON PROTEINPRODUKTEN IN -i(ASPERGILLUS) UND PROMOTOREN ZUR VERWENDUNG IN -i(ASPERGILLUS).
BG49717A3 (en) Method for preparing of chirudine
ATE178616T1 (de) Verfahren zur herstellung von biologisch aktivem protein (z.b. tgf)
DE3856580D1 (de) Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein
PT87083A (pt) Vascular-antikoaquilierende proteine dna die diese kodieren verfahren zu deren herstellung sowie deren verwendung
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
DE69231939D1 (de) Hybrid-Plasmid-Vektoren, die für Nitril-abbauende Enzyme kodierende Gene enthalten und Verfahren zur Herstellung von Amiden und Säuren
IT1223334B (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
ATE206761T1 (de) Plasmide zur herstellung von transgenen pflanzen welche in habitus und ertrag verändert sind
ATE18845T1 (de) Tierstreu sowie verfahren zu ihrer herstellung.
DE3887635D1 (de) Verfahren zur Herstellung von Produkten von Fremdgenen.
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
FI971100A0 (fi) Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi
ATE243741T1 (de) Zufuhr von genprodukten mittels mesangium-zellen
DE3576523D1 (de) Rekombinante dna enthaltende coryneformbakterien und verfahren zur herstellung von aromatischen aminosaeuren unter verwendung dieser bakterien.
DE3871410D1 (de) (phenylethenyl)phenylpropionaldehyd und verfahren zur herstellung von (benzoylphenyl)propionsaeure unter verwendung dieser verbindung.
IT8119759A0 (it) Umano, dna e plasmidi che polipeptide prodotto codificano per questa sequenza, microbiologicamente con la sequenza microorganismi che contengono di aminoacidi dell'interferone queste informazioni genetiche e processo per la loro preparazione.
DE58908072D1 (de) Verfahren zur ortsspezifischen Mutagenese von DNA und Entwicklung von Plasmidvektoren.
DE3485923D1 (de) Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid.
DE3787044D1 (de) Transformant einer tierischen zelle, verfahren zur herstellung des transformanten und dessen verwendung zur praeparation eines gewuenschten fremdgenproduktes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition